News & analysis, rated.
Breaking AI developments, in-depth guides, real-world case studies, and analysis — each one rated so you know what matters.
Map your chromatography tradeoffs before you purify
Researchers model how to balance speed and purity in two-step biopharmaceutical purification. The catch: decisions at step one lock in constraints at step two.
Infant Airway Grafts Beat Rib Cartilage in 3-Week Timeline
Researchers at Children's Hospital Philadelphia created a porcine cartilage graft seeded with patient cells that outperformed standard rib grafts in preclinical trials and cuts preparation time from 6 months to 3 weeks.
Nirrin and S.T. Japan bring protein quantitation to Japanese bioprocessing
Nirrin Technologies names S.T. Japan as exclusive distributor of TALOS protein measurement system. The partnership includes a demonstration unit for local customer evaluation.
Doctors warn ivermectin cancer claims outpace evidence as patient demand rises
Patient interest in using the antiparasitic drug ivermectin for cancer treatment is growing, but oncologists say the scientific evidence hasn't caught up with the hype. Here's what we know.
78% of Indian patients use AI to understand diagnoses, Bain report finds
India ranks among Asia-Pacific's most AI-ready healthcare markets, with three-quarters of consumers relying on GenAI for medical guidance. Here's what the adoption gap reveals about healthcare expectations.
KKR bids $1B+ for Medicover India hospital chain
KKR is in advanced talks to acquire Sweden's Medicover's majority stake in its Indian hospital operations for at least $1.05 billion. The deal would expand the buyout firm's healthcare portfolio in India's consolidating hospital market.
Healthcare AI is scaling faster than patient trust can follow
AI investment in healthcare hit $18 billion in 2025, yet 98% of patients drop digital-only apps within weeks. The gap between what vendors build and what patients will accept is widening.
Upper GI Cancer Misses Hit 8% — AI Landmarks Can Help
Combined endoscopy procedures are now routine, but upper GI quality standards lag far behind colonoscopy. AI landmark verification offers a path to catch what endoscopists miss.
Physicians want schedule control, not better AI scribes
Ambient documentation tools reduce charting burden, but hospitals reallocate freed time to more patients. McKinsey data shows 66% of physicians dissatisfied with schedules report burnout—far higher than those logging long hours on their own terms.
Neumora depression drug fails; biotech cuts 50% of staff
Neumora's failed depression treatment marks another setback for brain-focused biotech. The company is cutting half its workforce as the field faces repeated clinical disappointments.
Jazz licenses AbCellera's T cell tech in $4B deal
Jazz Pharmaceuticals and AbCellera struck a multi-billion dollar partnership to expand T cell engagers beyond blood cancers, where the approach has so far seen limited clinical wins.
UniQure files gene therapy as FDA leadership signals shift on approvals
UniQure's filing comes after two senior FDA officials departed, suggesting the agency may be willing to greenlight therapies it previously rejected. What changed at the regulator.